What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmaceutical companies…
Continue Reading
Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
What You Should Know:
– NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
– The framework provides a powerful suite…
Continue Reading
Dr. Francesco Pompei, CEO and Founder of Exergen Corporation
Accurate and frequent temperature monitoring is paramount when it comes to ensuring favorable patient outcomes in the medical community. When a patient is admitted to the…
Continue Reading
Shweta Maniar, Global Director of Healthcare & Life Sciences Solutions at Google
In recent months, I’ve had the opportunity to speak about the potential of AI at a variety of organizations and events. Along with…
Continue Reading
Otsuka Pharmaceutical’s North American CEO —Tarek Rabah — has deep respect for all the entrepreneurs who were at at the annual HLTH conference in Las Vegas touting their capabilities.
“I come from Lebanon, where we…
Continue Reading
Jennifer Goldsack, CEO, Digital Medicine Society (DiMe)
Dr. Shubs Upadhyay, Director of Medical Quality, Ada Health
Lucy Orr-Ewing, Chief of Staff and Head of Policy, Coalition for Health AI (CHAI)
As the digital health market continues to…
Continue Reading
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which…
Continue Reading
What You Should Know:
– Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
– This investment is in addition…
Continue Reading
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
